Inventor · disambiguated record
Eigen Peralta
Also filed as: PERALTA EIGEN
7 granted patents·8 pending applications·10 citations·filing 2017–2025
77Inventor score
Files withFATE THERAPEUTICS INC15
Top patents by PatentIndex Score
15 records- 0189US11413309B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2017·Granted Aug 16, 2022·4 cites·26 claims
- 0289US11096964B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2017·Granted Aug 24, 2021·4 cites·31 claims
- 0383US11932870B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2024·2 cites·14 claims
- 0476US2025032547A1Effector cells and use thereof for allogeneic adoptive cell therapies in solid tumorsFATE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0575US12203098B2Cells having solid tumor targeting backbone and use thereofFATE THERAPEUTICS INC·Filed 2023·Granted Jan 21, 2025·0 cites·30 claims
- 0673US12419870B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·16 claims
- 0772US12281329B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2021·Granted Apr 22, 2025·0 cites·27 claims
- 0872US2025228943A1Cells having solid tumor targeting backbone and use thereofFATE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0972US2024263135A1Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1070US2025215396A1Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1169US2025000904A1Effector cells and use thereof for allogeneic adoptive cell therapies in solid tumorsFATE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1263US2025388646A1Enhancing effector cell durability and efficacy in adoptive cell therapiesFATE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1357US2023390337A1Engineered ipsc and persistent immune effector cellsFATE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1455US12036241B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2024·0 cites·21 claims
- 1553US2024033355A1ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLSFATE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eigen Peralta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →